People living in [a] rural area or [a] community with more social-economic challenges were less likely to be prescribed with this treatment. The class of medications called glucagon-like peptide-1 (GLP-1) agonists are prescribed to treat Type 2 diabetes, a metabolic condition that increases the risk of cardiovascular disease
De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrm E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis
If you have any questions, feel free to contact our support team or your healthcare provider for additional guidance
All patients underwent standard medical therapy post-PCI, incorporating antiplatelet agents, statins, and ACEI/ARB/ARNI, beta-blockers to reduce ischemic events and improve outcomes
41 YamotoMFukumotoKTakahashiTMiyakeHNakayaKNomuraAet al